Finance

Lists
42C:SGX
IX Biopharma Ltd
0,52 SGD
-0,94%
(-0,0050) 1D
16 қаз., 17:10:09 GMT+8  ·   SGD
All symbols
SymbolPriceChange% Change
Generating top insights for 42C...
Open
0,53 SGD
High
0,56 SGD
Low
0,52 SGD
Mkt. cap
575,40 млн
Avg. vol.
18,47 млн
Volume
25,41 млн
52-wk high
0,62 SGD
52-wk low
0,08 SGD
EPS
-0,01 SGD
Shares outstanding
1,10 млрд
No. of employees
37
Open
0,53 SGD
High
0,56 SGD
Low
0,52 SGD
Mkt. cap
575,40 млн
Avg. vol.
18,47 млн
Volume
25,41 млн
52-wk high
0,62 SGD
52-wk low
0,08 SGD
EPS
-0,01 SGD
Shares outstanding
1,10 млрд
No. of employees
37
News stories
From web sources and news partners
About IX Biopharma Ltd
CEOEddy Lee
Employees37
Founded2004
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in SGD
Loading Previous Earnings...
Revenue
Net income
All values in SGD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
1,59 млн
1,59 млн
1,59 млн
2,09 млн
Cost of goods sold
1,18 млн
1,18 млн
983,00 м.
1,08 млн
Cost of revenue
1,18 млн
1,18 млн
983,00 м.
1,08 млн
Research and development expenses
203,00 м.
203,00 м.
769,00 м.
1,31 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,72 млн
1,72 млн
1,71 млн
4,30 млн
Operating expense
1,94 млн
1,94 млн
2,48 млн
5,63 млн
Total operating expenses
3,12 млн
3,12 млн
3,46 млн
6,71 млн
Operating income
-1,53 млн
-1,53 млн
-1,87 млн
-4,62 млн
Other non operating income
66,00 мың
66,00 мың
79,00 мың
-243,00 м.
EBT including unusual items
-1,03 млн
-1,03 млн
-915,00 м.
-5,01 млн
EBT excluding unusual items
-1,03 млн
-1,03 млн
-915,00 м.
-4,75 млн
Income tax expense
500,00
500,00
1,00 мың
7,00 мың
Effective tax rate
-0,05%
-0,05%
-0,11%
-0,14%
Other operating expenses
-
-
-
-
Net income
-1,03 млн
-1,03 млн
-916,00 м.
-5,02 млн
Net profit margin
-64,76%
-64,76%
-57,65%
-240,35%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
6,00 мың
Interest expense
-201,50 м.
-201,50 м.
-164,00 м.
-123,00 м.
Net interest expenses
-201,50 м.
-201,50 м.
-164,00 м.
-117,00 м.
Depreciation and amortization charges
-
-
-
-
EBITDA
-1,44 млн
-1,44 млн
-1,78 млн
-4,53 млн
Gain or loss from assets sale
-
-
-
-64,00 мың
AI content may include mistakes. Learn more
Google қолданбалары